Shanxi Fenjiu: 22% More Volume but Only 7.5% More Revenue in 2025, Q1 2026 Out-of-Province Sales Fell 15% While Dealers Grew, and CNY123.52 Sits Above Conservative Value

Q1 2026 revenue fell 9.68% to CNY 14.923bn and attributable profit fell 19.03% to CNY 5.383bn. For baijiu, this quarter is disproportionately important because Chinese New Year concentrates gifting, family gatherings and business banquets early in the year: Q1 alone represented 42.7% of Fenjiu’s 2025 revenue and 54.3% of its full-year attributable profit. The Q1 2026 report, 《山西杏花村汾酒厂股份有限公司 2026 年第一季度报告》 (“2026 First Quarter Report”), deserves more weight than an ordinary seasonal miss.

The geography of that decline is more revealing than the group headline. Shanxi revenue in Q1 was essentially flat at CNY 6.087bn, up 0.06%, while out-of-province revenue fell 15.41% to CNY 8.794bn. At the same time, Fenjiu’s out-of-province distributor count increased by a net 52 during the quarter to 2,978. The national network was still getting larger while the revenue reported through those markets shrank. That is precisely the pattern an investor should watch when testing whether national expansion remains economically productive.

There is also evidence against the harshest interpretation of Q1. Company inventory declined by about CNY 0.74bn from year-end, contract liabilities increased by about CNY 0.90bn, and operating cash flow rose 17.46% to CNY 8.254bn despite the profit decline. External channel checks around the Spring Festival put Qinghua 20 wholesale pricing around CNY 350–365 per bottle and channel inventory below roughly three months, with some checks reporting a recovery toward CNY 365 before the holiday. Those numbers come from channel surveys, not audited company disclosures, and should be treated accordingly.

Those pieces fit a controlled channel reset responding to weaker demand better than they fit either extreme narrative. Management appears to have reduced shipment pressure and allowed inventories to normalize. Stronger cash collection and rising contract liabilities argue against a broad distributor-financing seizure. Yet genuine demand softness is also present: industry output, revenue and profit all contracted in 2025, Fenjiu’s out-of-province sales fell sharply in the highest-value quarter, and FY2025 already showed lower realized revenue per unit of volume. A pure “voluntary destocking with demand intact” explanation is too generous.

Through FY2025, Fenjiu was still gaining category share. China’s scale baijiu output fell 12.1% to about 3.549 million kiloliters in 2025; industry sales revenue fell about 7.5% and industry profit fell about 13.3%, while Fenjiu delivered +7.52% revenue and flat profit. The China Alcoholic Drinks Association described 2025 as a deep structural adjustment marked by contraction in production, revenue and profit and a shift away from the old volume-expansion model.

This distinction matters. Fenjiu did not enter 2026 as a company that had already been losing broad market share for several years. It entered as a share gainer whose own revenue quality was deteriorating while competitors deteriorated faster. The question now is whether that relative strength can survive a second phase of the cycle in which distributors demand healthier economics and consumers trade down.

That portfolio structure is the main reason Fenjiu is analytically different from Moutai and from many strong-aroma peers. Qinghua 20 and the broader Qinghua family carry brand elevation and high gross margins. Bofen occupies the high-turnover, affordable bottle segment and is exposed to everyday consumption rather than only banquets and gifting. Industry reporting cited by Fenjiu’s own website estimated Bofen’s 2024 sales scale around CNY 9bn and described it as growing across several provincial markets. The company has stated that Qinghua 20 and Bofen have each reached the scale of CNY 10bn-class products, although it does not provide audited SKU-level revenue and gross-margin disclosure.

That last qualification is important. Investors cannot independently calculate how much of FY2025’s volume surge came from Bofen, how much Qinghua pricing softened, or the exact gross-margin contribution of Qinghua 20 versus Bofen. The filing reports Fenjiu-branded alcohol and “other alcohol,” not a clean audited price-band P&L. Zhuyeqing, Xinghuacun, Panama, Bofen and Qinghua have to be analyzed partly through channel evidence and portfolio economics, not through a segment profit statement.

National expansion is also more nuanced than a simple “dealer count equals growth” story. At the end of 2025, Fenjiu had 2,926 out-of-province distributors, net 71 more than a year earlier. Using total out-of-province alcohol revenue as a rough numerator gives about CNY 8.61m revenue per year-end Fenjiu distributor versus roughly CNY 7.84m in 2024, an increase of about 10%. Because the numerator includes some other alcohol and the denominator is a year-end stock rather than an average, this is only a proxy. It still suggests 2025’s out-of-province growth was not manufactured solely by adding dealer names. Q1 2026 is the first clear reversal of that relationship.

The balance sheet gives management time. Year-end cash was CNY 9.77bn; the company had no meaningful conventional financial leverage, and fixed assets were only CNY 3.25bn against CNY 56.32bn of total assets. Contract liabilities were CNY 7.01bn and inventory CNY 14.39bn. The latter number needs baijiu-specific interpretation because aged raw liquor is an economic asset rather than merely unsold finished goods. The leading warning indicator is therefore the combination of finished-goods/channel inventory, wholesale prices and dealer prepayments, not headline inventory alone.

Capital returns have become material enough to change the stock’s character. The FY2025 cash distribution was CNY 6.56 per share, about CNY 8.00bn in aggregate, equal to 65.35% of attributable profit. At the August 14 price, that is a trailing cash yield of about 5.31%. The problem is that the distribution also consumed essentially all of 2025’s CNY 7.82bn crude free cash flow after total capex. A larger dividend reduces the opportunity cost of waiting for growth to recover, but it does not repair weak cash conversion.

The equity market has already repriced much of the old growth narrative. Fenjiu reached an all-time share-price high around CNY 380.77 in July 2021; the August 14, 2026 close of CNY 123.52 is about 67.6% below that peak and roughly 34.5% below its level a year earlier. Its TTM P/E is around 13.7 times and P/B around 3.35 times, both near the low end of historical trackers’ ranges; the trailing dividend yield exceeds 5%.

Yet the headline P/E understates the valuation burden if 2025’s cash conversion is a new normal. On FY2025 earnings the stock trades at 12.3 times reported profit, but at roughly 19.3 times crude free cash flow after all capex. After estimating maintenance rather than growth capex, I calculate an owner-earnings multiple around 17.3 times. That is still far below the multiple the market gave Fenjiu at the height of the national-expansion story, but it is not the valuation of a business whose earnings can permanently decline without damaging shareholder returns.

The central disagreement sits between two plausible pictures. The bullish picture says Fenjiu is using an industry downturn to clean the channel, Qinghua 20 pricing and inventories are better than most second-tier premium products, Bofen benefits from consumers seeking value, national share gains continue, and a 13.7-times TTM P/E plus a 5%-plus dividend yield already prices a severe slowdown. The bearish picture says 2017–2024 was an unusually favorable baijiu upcycle combined with distributor expansion; 2025’s volume/revenue divergence and falling contract liabilities exposed the limits of sell-in growth; and Q1 2026’s out-of-province decline is the first visible break in the nationalization engine.

Qualitative portrait: company in transition. The brand, balance sheet and distribution system still look like assets of a high-quality consumer franchise. The earnings model is transitioning from double-digit sell-in growth and premiumization toward channel health, cash returns and a lower normalized growth rate. Whether that transition preserves returns on capital will decide the next five years.

Vertical analysis and financial history

Fenjiu’s operating history is much older than the listed company, but equity investors should distinguish brand mythology from corporate history. The modern listed entity was reorganized as a joint-stock company in December 1993 and began trading in Shanghai on January 6, 1994. Company materials describe it as the first listed Chinese baijiu company and the first listed company from Shanxi. Its corporate roots came out of a state-owned distilling system in Xinghuacun, not from a founder-led private enterprise.

The IPO price was CNY 3.50 per share. Historical issuance records indicate an offering of roughly 78 million shares, implying about CNY 273m of gross issuance value and about CNY 252m of net funds raised. Surviving digitized public records are much better on the issuance itself than on a consistently adjusted post-IPO market capitalization, so I do not force a reconstructed listing valuation that cannot be independently checked to the same standard as modern disclosures.

The ownership origin shaped the company for decades. Fenjiu did not have a founder retaining a controlling economic interest and taking entrepreneurial risk in the contemporary sense. Control remained with Shanxi state capital through Fenjiu Group. That created a different governance problem: the strategic question was how to make a provincial state-owned consumer company behave more like a market-oriented branded-goods organization without relinquishing public control.

The first useful stage for modern investors is not the 1994 listing itself but the long pre-reform period that followed. Fenjiu possessed nationally recognized brand heritage and a distinctive light-aroma product, yet commercial performance lagged the strongest premium baijiu companies. Its historical moat was cultural recognition and product identity; its weakness was translating that recognition into national channel productivity and premium pricing. By the middle of the 2010s, that gap between the reputation of the brand and the economics of the listed company had become the central strategic issue.

The decisive turn came in 2017. Shanxi’s state-owned-assets authorities made Fenjiu Group a provincial reform pilot and signed a three-year management target responsibility agreement. Contemporary reports described explicit revenue and profit targets and a management-accountability mechanism under which failure could cost senior executives their positions. The target framework called for very high alcohol-revenue growth in 2017–2019 and roughly 25% annual profit growth.

This mattered for more than its headline targets. It changed the institutional contract surrounding management. The state shareholder delegated more operating latitude while demanding measurable commercial results. That allowed management to rationalize products, expand channels and use more market-oriented incentives. In retrospect, the reform was not merely an investor-relations story: it preceded a multi-year acceleration in sales, profit and national distribution.

The 2018 introduction of China Resources as a strategic shareholder reinforced that turn. China Resources Enterprise and an affiliated fund acquired 11.45% of Shanxi Fenjiu for CNY 5.16bn, making the CR-backed vehicle the second-largest shareholder. China Resources’ own account says the investment obtained two board seats and was designed to bring experience in consumer operations, branding, supply chains and market execution into Fenjiu’s mixed-ownership reform.

The transaction was consequential because it provided external commercial discipline without ending state control. Fenjiu Group remained dominant. China Resources had enough ownership and board presence to matter, but not enough to determine the company’s direction. This structure subsequently proved capable of operating through a rapid expansion phase, although it also means minority investors remain dependent on the capital-allocation priorities of a provincial SOE controller.

From roughly 2017 through 2021, the business entered what can reasonably be called its marketization and national-expansion phase. The core economic change was channel multiplication outside Shanxi paired with upward product mix. Qinghua led the push at the premium end; Bofen provided volume and consumer recruitment; old regional barriers weakened as distributors were added in surrounding provinces and then farther south. Revenue in 2021 reached CNY 19.97bn and attributable profit CNY 5.31bn.

The equity market rewarded both the earnings growth and the change in perception. Fenjiu stopped being priced merely as an underperforming regional SOE liquor producer and increasingly traded as a national premiumization story. Its share price eventually reached about CNY 380.77 in July 2021. That peak reflected far more than one year’s profit: investors were capitalizing years of expected national penetration, premium-mix gains and above-sector earnings growth.

That period is the reason a long-horizon quality screen now identifies Fenjiu so easily. It is also the reason the screen is dangerous if interpreted mechanically. The ten-year window captures the reform itself, a powerful Chinese baijiu premiumization cycle, national distributor expansion, very rapid earnings growth and multiple expansion. High historical ROE over that window tells us that the transformation worked; it does not tell us the next decade can reproduce the same economics.

The second modern stage, roughly 2022–2024, was the crystallization of the new business model. Revenue rose from CNY 26.21bn in 2022 to CNY 36.01bn in 2024, and attributable profit from CNY 8.10bn to CNY 12.24bn. The company increasingly described Qinghua and Bofen as its two large-scale anchor products. Out-of-province revenue became the majority of the business, and the central investor debate moved from “can Fenjiu nationalize?” toward “how far can Fenjiu premiumize while nationalizing?”

Financially, this phase looked exceptional. Profit grew faster than revenue for several years; ROE remained above 30%; financial leverage was negligible. Those economics helped support a premium market narrative even as the share price began declining from its 2021 high. The fall in the stock began before the fundamental downturn: investors progressively reduced the multiple they were willing to pay for baijiu growth as the category’s demographic, inventory and macroeconomic risks became harder to ignore.

The current stage began during 2025, not in April 2026.

The 2021–2022 figures come from the company’s earlier annual disclosures; the 2023–2025 comparatives are reproduced in the 2025 Annual Report. On a cumulative basis, operating cash flow over these five years was about 95.9% of attributable profit, so the long-run cash conversion is not poor. The concern is the direction: the ratio fell to 0.74 in 2025 at the same time earnings stopped growing.

Working capital explains much of that 2025 cash-flow drop. The cash-flow reconciliation shows a CNY 1.12bn increase in inventory, a CNY 1.13bn cash drag from operating receivables and a CNY 1.43bn cash drag from operating payables. Contract liabilities declined from CNY 8.67bn to CNY 7.01bn, down about 19%. For a baijiu producer whose distributors prepay for shipments, weaker contract liabilities can precede weaker reported sales because they reflect less cash already committed by dealers.

The 2025 volume data supply the business explanation. Production rose 7.41%, sales volume jumped 21.99%, and physical inventory volume declined 9.32%. Revenue grew just 7.52%. Fenjiu was clearing or selling materially more volume without equivalent revenue capture. That can happen because lower-priced products become a larger part of the mix, because promotional realization falls, or because both occur together. The filing does not disclose enough SKU-level data to apportion the effect precisely.

Geographical margin data complicate the nationalization story. Shanxi revenue fell 0.81% in 2025 to CNY 13.39bn while out-of-province revenue rose 12.64% to CNY 25.20bn. Gross margin was 75.99% in Shanxi and 74.40% outside, and both fell year on year. Expanding geographically still added revenue, but it did not prevent consolidated margin pressure.

Distributor arithmetic argues that 2025 was not yet simple channel stuffing. Fenjiu’s outside-province distributor base increased only about 2.5%, from an implied 2,855 to 2,926, while out-of-province revenue rose 12.64%. A rough revenue-per-year-end-dealer proxy still increased close to 10%. The more concerning signal is that the company was adding and turning over a large number of dealers: 208 additions and 137 exits outside Shanxi during 2025. A network with substantial churn can keep headline dealer counts stable while underlying dealer economics deteriorate.

The last four reported quarters show how quickly the earnings distribution changed.

Baijiu seasonality makes absolute quarter-to-quarter comparisons misleading, and Q4’s small absolute contribution is a seasonal artefact rather than evidence of decay: on a year-on-year basis Q4 2025 revenue rose 24.51%, the fastest quarter of the year, and attributable profit fell only 5.72%, a milder decline than Q2’s 13.50%. The visible break in the exit rate is Q1 2026, not Q4 2025. The 2025 Annual Report supplies the quarterly data, and the 2026 First Quarter Report supplies the latest quarter.

The balance sheet is still a source of resilience, not of stress. At the end of 2025, cash was CNY 9.77bn and total equity roughly CNY 40.13bn. Fixed assets were CNY 3.25bn, construction in progress CNY 2.88bn, and the company had essentially no conventional borrowing burden. Its largest capital risk is not refinancing; it is investing too much in capacity during a period when category demand is contracting.

That capacity commitment is visible in construction in progress, which rose 42.2% in 2025. The company specifically attributed the increase to the “Fenjiu 2030 technological-upgrade raw-liquor production and storage expansion project” and the “Fenqing 20,000-ton raw-liquor capacity project.” Capex paid in cash rose from CNY 638m in 2024 to CNY 1.194bn in 2025.

This creates a new capital-allocation tension. Fenjiu is simultaneously paying out about two-thirds of earnings and expanding future production/storage capacity. In a renewed growth cycle, those choices can coexist comfortably. In a structurally shrinking category, returns depend on whether Fenjiu takes enough share from weaker producers to fill the additional high-quality capacity.

The share-price history is the capital-market version of the same story. The 2017 reform changed the expected growth rate; the 2018 China Resources transaction strengthened confidence in execution; national expansion and premiumization carried the stock into its 2021 peak. Since then, multiple compression has done much of the work even before earnings fell. At CNY 123.52 on August 14, 2026, Fenjiu is roughly one-third of its 2021 peak price.

Historical valuation trackers differ in their exact percentile calculations, but they agree on direction. One current tracker reports a TTM P/E near 13.7 times and places it in a low-single-digit historical percentile; another places the ten-year P/E at the extreme low end of its range. Methodological differences in earnings periods and outlier treatment mean the precise percentile should not be fetishized. The substantive fact is that investors have stripped away most of the old growth multiple.

The capability proven by the vertical history is commercial transformation: Fenjiu converted brand heritage into national distribution and earnings growth once governance incentives changed. The capability that remains unproven is managing that enlarged network through a prolonged demand contraction without sacrificing premium mix.

Business model, moat, industry and horizontal peers

Fenjiu’s income statement looks simple because almost all revenue ultimately comes from selling alcohol. Economically it contains at least four different businesses.

Qinghua Fenjiu is the valuation-bearing premium franchise. Qinghua 20 operates primarily in the several-hundred-yuan price range where business dining, banquets and gifting matter; higher Qinghua variants reach toward the premium price bands occupied by the strong-aroma leaders. These products contribute brand elevation and, by inference from the group’s margin structure, disproportionate gross profit per bottle. The company does not disclose Qinghua’s audited revenue or gross margin separately.

Bofen is economically different. It is a high-turnover naked-bottle product positioned around mass everyday consumption. Industry reporting reproduced on Fenjiu’s own website estimated Bofen sales around CNY 8bn in 2023 and roughly CNY 9bn in 2024, with strong growth in provinces such as Henan, Liaoning and parts of central and eastern China. Dealer economics run on turnover, not on very high absolute gross profit per bottle.

Old Baifen, Panama and related mid-tier products bridge the gap. They matter because this CNY100–300-ish consumption region is less dependent on prestige gifting than ultra-premium baijiu and can absorb consumers trading down from more expensive bottles. The risk is that mix migration into these products stabilizes volume while lowering group revenue per liter and gross margin.

Zhuyeqing is a separate economic niche. It is a herbal liqueur with a different consumer proposition, less direct price comparability with mainstream baijiu and a smaller profit pool. The annual report folds it into “other alcohol,” where 2025 revenue was CNY 1.15bn and gross margin 51.62%, far below the 75.67% margin of Fenjiu-branded alcohol. It cannot carry the listed company’s valuation.

The 2025 revenue structure makes clear where the money comes from.

Source: 《2025 年年度报告》 (“2025 Annual Report”).

This is why any valuation thesis centered on Zhuyeqing is misplaced. Almost all economic value is carried by the Fenjiu brand family, and within that family the unresolved issue is the internal mix between Qinghua, mid-tier products and Bofen.

Fenjiu’s cost structure resembles a branded consumer company more than a conventional manufacturer. Production inputs matter, but alcohol’s selling price vastly exceeds direct manufacturing cost. In 2025 raw-material cost was about CNY 5.94bn and rose 20.88%; labor was about CNY 2.85bn and rose only 1.37%. The bigger determinant of incremental profit is mix, taxation and selling support, not factory utilization alone.

Sales and marketing are partly variable but strategically sticky. Advertising and business-promotion expense reached CNY 2.62bn in 2025; total selling expense was CNY 4.10bn. Management can cut promotions in a downturn, but doing so while distributors are losing money or retail prices are weakening can worsen sell-through. That means operating leverage becomes negative when revenue falls: gross-profit dollars decline while much of the channel-defense budget must remain.

Consumption tax adds another form of operating leverage. Fenjiu paid CNY 5.80bn of consumption tax in 2025, before urban-maintenance and education surcharges. Total tax and surcharge expense was CNY 6.92bn. The tax burden increased faster than revenue in 2025 and is large enough that small changes in product mix and taxable realization materially affect net profit growth.

Capital intensity is moderate rather than trivial. Mature baijiu does not require semiconductor-like continual reinvestment, but high-quality raw liquor must be produced, stored and aged; expansion projects tie up capital years before some products are monetized. Construction in progress of CNY 2.88bn and the 2030 expansion program show that Fenjiu is still investing as a share taker, not behaving as a business that has accepted terminal maturity.

The first genuine moat is the Fenjiu brand’s ownership of the light-aroma category in consumer consciousness. This is more than a marketing slogan. Fenjiu is one of the standard-setting names for light-aroma baijiu, and industry research places the Fenyang production region at the center of the segment. Estimates of clean-aroma market size vary, so I do not assign a precise market share to Fenjiu from non-audited category studies, but its CNY 37bn-plus Fenjiu-brand revenue makes it the dominant listed economic franchise in the aroma type.

The second moat is portfolio breadth. A single premium SKU can suffer badly when banquet and gifting demand contracts. Fenjiu has Qinghua at the top and Bofen at the mass end. That barbell lets the company participate in both premiumization and consumer trading-down. The FY2025 volume/revenue divergence shows the limitation: portfolio breadth can protect volume and market share while diluting revenue quality.

The third moat is distribution density. By the end of 2025 Fenjiu had 560 Fenjiu distributors inside Shanxi and 2,926 outside. E-commerce sales were CNY 2.43bn, up 15.21%. A national route-to-market of that scale is costly for a challenger to reproduce, particularly when paired with a brand consumers already know.

That same channel can become an anti-moat when incentives break. Baijiu distributors prepay, warehouse inventory, manage local pricing and absorb working-capital risk. If factory targets grow faster than end demand, a large dealer network can temporarily turn sell-in into reported growth and then amplify the downturn when dealers stop taking inventory. Fenjiu’s falling 2025 contract liabilities and Q1 2026 outside-province contraction are tests of whether its channel advantage remains healthy.

The fourth moat is production know-how and aged-liquor inventory. The value of inventory in baijiu cannot be read like consumer electronics inventory because aging can improve economic value and supply future premium products. Fenjiu had CNY 14.39bn of inventory at the end of 2025. For a company expanding Qinghua, having sufficient high-quality base liquor is strategically valuable. It does not remove demand risk: aged liquor only earns premium returns when the brand can sell it at premium prices.

There are no meaningful network effects or switching costs in the technology sense. Consumers can choose strong-aroma, sauce-aroma or other light-aroma products bottle by bottle. Patents are not the core moat. This leaves brand, taste identity, route-to-market and scarce accumulated liquor as the actual defenses.

The real moat is the combination of category ownership, a barbell product portfolio and national distribution; none of those protects the company from over-shipping the channel or from a permanent fall in social drinking occasions.

Governance is inseparable from the business. Fenjiu Group held 56.65% at year-end 2025, leaving Shanxi state capital in control. The CR-backed Huachuang Xinrui vehicle held 9.17%, down from the 11.45% originally acquired in 2018. The strategic shareholder has monetized part of a very successful investment, but it remains formally involved in governance: in June 2026 the more-than-5% shareholder nominated China Resources Enterprise president Chu Zhuolun as a non-independent director candidate.

Chairman Yuan Qingmao came from senior positions in Shanxi transportation and state-owned enterprise management and is a senior accountant by training. He has chaired Fenjiu during the later nationalization phase. General manager Wu Yuefei was identified in the company’s February 2026 corporate communications as the operating head alongside Yuan.

Two finance/IR posts changed hands immediately before this report’s base date. On July 27, 2026, deputy general manager and chief accountant Wang Huai resigned those management roles for a work change, remaining only a Party-committee member; the board appointed Song Yapeng, a long-serving Fenjiu finance and audit executive, as chief accountant. Board secretary Xu Zhifeng also departed for a work change, and Chen Xi was appointed. Both announcements state that the departing executives reported no disagreement with the board or unfulfilled public commitments.

I treat the timing as something to monitor, not as evidence of an accounting problem. The 2025 financial statements received a standard unqualified audit opinion from Tianheng Certified Public Accountants, and the report disclosed no conventional debt stress or material non-operating shareholder fund occupation.

Capital allocation has become more shareholder-friendly. The FY2025 distribution of about CNY 8.00bn equaled 65.35% of attributable profit, and the balance sheet can support it. The discipline test is whether management will protect that payout only when cash generation supports it, rather than treating a high dividend as a substitute for correcting channel economics.

The wider industry is now in the opposite environment from the one that supported Fenjiu’s reform years. According to industry figures cited in Wuliangye’s 2025 annual disclosure, national scale-baijiu output fell 12.1% in 2025 to 3.549 million kiloliters, sales revenue declined 7.5% to CNY 572.4bn and industry profit declined 13.3% to CNY 188.4bn. The China Alcoholic Drinks Association’s May 2026 assessment described the sector as moving into a deep structural adjustment in which production, revenue and profit were simultaneously contracting.

This is an unusual consumer cycle because both volume and price architecture are under pressure. China has produced less baijiu for years: industry output is far below its 2016 peak, and 2025 was another double-digit contraction. At the same time, leading brands expanded production capacity and distributors accumulated inventory during earlier premiumization. Lower end demand therefore interacts with a channel inventory cycle.

The profit pool remains extraordinarily concentrated. Xinhua’s review of 2025 listed-company data found that the six large listed names, including Moutai, Wuliangye, Fenjiu, Luzhou Laojiao, Yanghe and Gujing Gongjiu, accounted for the overwhelming majority of profit among the listed baijiu group. Concentration can favor Fenjiu even while the category contracts because weak regional producers lose shelf space and distributors consolidate around nationally liquid brands.

The opposing structural force is consumption occasion. The industry association itself now talks about a move away from reliance on high-end government/business consumption toward personal enjoyment, family gatherings and lighter social occasions. Fenjiu has responded with lower-alcohol and younger-oriented products, but these new formats are not yet large enough in disclosed financials to offset a material decline in traditional premium baijiu.

In cycle terms, Fenjiu is exposed simultaneously to a consumer cycle, an inventory cycle and a policy/social-occasion cycle. In an upcycle, distributor prepayments, premium mix and Qinghua pricing can cause profit to grow much faster than volume. In a downcycle, those variables reverse: dealers cut inventory, consumers trade down, Bofen keeps physical volume healthy, and consolidated gross profit grows more slowly than liters sold.

The current competitive field is broad enough to require several peer archetypes, not one comparator.

† Wuliangye’s 2025 and Q1 2026 year-on-year comparisons are distorted by a major prior-period revenue-recognition correction; the apparent Q1 rebound should not be read as clean organic acceleration. ‡ Yanghe’s TTM multiple is inflated by collapsed trailing earnings. § Approximate, derived from its current price and trailing earnings rather than a common vendor series. Fenjiu, Luzhou, Wuliangye and Yanghe valuation observations are consistent with current peer screens.

Luzhou Laojiao is the most useful listed comparison for profit quality. It is a strong-aroma producer centered on Guojiao 1573 and other upper-price products. Its 2025 revenue was only two-thirds of Fenjiu’s, yet attributable profit of CNY 10.83bn was close to Fenjiu’s CNY 12.25bn. That 42% net margin illustrates the economic power of a more premium-concentrated mix. The cost is greater exposure when high-end pricing and business demand weaken; both its 2025 revenue and Q1 2026 revenue declined more sharply than Fenjiu’s.

Customers choose Luzhou Laojiao when they want the recognition of Guojiao 1573 and strong-aroma flavor in premium occasions. Fenjiu’s advantage is a broader ladder down to Bofen and a distinctive light-aroma identity; Luzhou’s is superior profit per yuan of sales. The competitive collision is most intense when Qinghua tries to move upward while Luzhou’s mid- and upper-tier products move downward on price during an industry correction.

Yanghe became a very different company. Its Jiangsu-centered banquet franchise and once-broad national aspirations produced large scale in the prior cycle, but 2025 revenue collapsed 33.5%, profit 66.9%, and operating cash flow turned negative. That makes Yanghe a warning about what happens when a large distributor-led baijiu system loses momentum: the earnings denominator can fall much faster than revenue.

Gujing Gongjiu is the regional-fortress comparator. It has deep distribution and banquet consumption in Anhui and surrounding markets and competes with Fenjiu in mid-premium price bands. Its 2025 revenue fell 20.1% and Q1 2026 revenue another 18.6% year on year, substantially weaker than Fenjiu. Fenjiu’s national footprint and mass bottle franchise are stronger; Gujing’s local market depth remains formidable.

Wuliangye represents the high-end strong-aroma benchmark, but its current reported financials are unusually hard to use. In 2026 it corrected prior-period revenue recognition, sharply reducing reported 2025 revenue and profit and mechanically creating a large positive Q1 2026 comparison. The accounting correction does not mean Wuliangye’s brand economics disappeared; it means current growth percentages are unsuitable for a clean operating comparison.

Moutai sits outside the direct peer set. The market pays for scarcity, status, an extraordinary direct-to-consumer price umbrella and sauce-aroma brand power. Its current TTM P/E around 20 times is a useful ceiling reference for how the market values a mature but exceptional baijiu cash franchise, but applying a Moutai multiple to Fenjiu would ignore Fenjiu’s lower average selling prices, higher distributor dependence and greater sensitivity to mass and sub-premium demand.

Fenjiu’s ecological niche is unusually attractive but not monopolistic: it is the national light-aroma champion with a barbell between mass-market volume and sub-premium/premium branding. Its most direct profit pool is the CNY50–100 high-line naked-bottle segment at the bottom and the several-hundred-yuan banquet/business segment at the top. Bofen can take volume from smaller light-aroma and low-end regional brands; Qinghua takes wallet share from strong-aroma and sauce-aroma alternatives.

The competitive danger comes from both directions. If consumers keep trading down, Bofen can gain units while consolidated margin falls. Should premium competitors discount aggressively, Qinghua’s price umbrella weakens. And if Fenjiu responds by pushing more product through distributors, channel inventory rises and the national network stops being an asset.

Current fundamentals and channel diagnosis

Start with FY2025’s bridge from revenue growth to flat earnings; that is the clearest way into Fenjiu today.

Main-business revenue grew about 7.5%, but product cost grew materially faster. Fenjiu-brand cost rose 14.31%, nearly twice the rate of Fenjiu-brand revenue. Gross margin fell 1.40 percentage points. Total tax and surcharge expense increased by nearly CNY 1bn, and selling expense increased by CNY 375m. Management expense was roughly flat, so there was no broad corporate-cost blowout; the pressure was concentrated in the economics of selling alcohol itself.

The table below isolates the major pressure points.

Source: 《2025 年年度报告》 (“2025 Annual Report”); ratios calculated from disclosed values.

Tax burden up roughly 1.4 points, Fenjiu gross margin down 1.4 points, selling-expense intensity up a quarter point: that is enough to explain why operating profit failed to follow sales. There were offsets elsewhere, so these effects cannot simply be added into an exact net-margin bridge, but they identify where the incremental economics went.

The timing inside 2025 is also instructive. In the first half, revenue was still up 5.35%, but selling expense increased 19.1% and operating cash flow fell 24.6%. The company was spending more to support growth before the annual top-line number looked weak.

Q4 looks alarming in absolute terms: only CNY 5.79bn of revenue and CNY 0.84bn of attributable profit, just 6.9% of FY2025 attributable profit. That is seasonality rather than decay. Against Q4 2024’s CNY 4.65bn, Q4 2025 revenue rose 24.51% and profit fell only 5.72%. So Q1 2026 is not the continuation of a visibly collapsing exit rate. A shipment-heavy Q4 followed by a Q1 digestion period fits the same numbers, and that reading is the less comfortable one, because it makes part of the Q4 acceleration channel loading rather than end demand.

The Q1 geographical split then identified the fault line. Shanxi revenue was CNY 6.087bn, basically unchanged. Outside Shanxi, revenue fell to CNY 8.794bn from roughly CNY 10.40bn a year earlier. Fenjiu products overall declined 9.24%, while other alcohol fell 37.25%. Agency-channel revenue declined 9.60%, and direct/group-buy/e-commerce revenue declined 11.55%. This was broad enough that a single weak minor product cannot explain it.

Distributor data make the outside-province result particularly important. Fenjiu ended Q1 with 2,978 out-of-province distributors. During the quarter it added 230 and removed 178, for a net increase of 52. A network can legitimately be optimized through simultaneous entry and exit, but a 15.4% revenue decline alongside net network expansion means revenue productivity per distributor is falling sharply at least in the near term.

Company-level inventory moved in the opposite direction. Inventory on the balance sheet fell from CNY 14.39bn at December to about CNY 13.65bn at March, a CNY 0.74bn decline. Contract liabilities increased by about CNY 0.90bn. Operating cash flow increased 17.46%. These are favorable signs for factory-level working capital.

They do not prove social inventory has cleared. When the producer reduces shipments, its own finished inventory can fall or change in composition while distributors and retailers still hold product. Contract liabilities are encouraging because they indicate dealer cash commitment, but the most direct missing data are SKU-level channel weeks of inventory and wholesale-to-invoice price spreads.

For Qinghua 20, there is enough external evidence to form a provisional view. A February 2026 Spring Festival channel survey reported dealer repayment around 25% with a Q1 target near 30%, roughly 8% sell-through growth at the surveyed distributor, and wholesale pricing recovering to around CNY 365. Other channel work around April put Qinghua 20 around CNY 350 and inventory below three months.

CNY 350–365 is not evidence of extraordinary pricing power. It is still materially different from a product in uncontrolled free fall with six months of inventory. The external data support the view that Qinghua 20 remains one of Fenjiu’s healthier SKUs even while the corporate top line falls.

For Qinghua 25, the evidence is less satisfactory. Multiple 2026 channel-oriented reports claim very rapid growth, in some cases close to doubling from a low base, and management-linked media coverage highlights it as an emerging product. I did not find a sufficiently reliable, dated, independent wholesale-price series for Qinghua 25 to put a hard batch price into an investment-grade model. The CNY 489 figure associated with the new Qinghua 25 “Huashen Ling” promotion is a product program price, not a clean wholesale-market observation, so treating it as a batch price would be misleading.

That is an important research limitation, not a cosmetic one. Qinghua 25 is supposed to help Fenjiu build a deeper premium ladder between Qinghua 20 and higher Qinghua variants. Without a wholesale-price and inventory series, the market cannot yet distinguish genuine consumer pull from launch support as confidently as it can for Qinghua 20.

The cleanest diagnosis of Q1 is a combination of deliberate destocking and real end-demand weakness.

The evidence favors “controlled de-loading of the channel in response to softer demand” over either “pure accounting destocking” or “structural collapse in the core franchise.” Factory inventory fell, contract liabilities and cash flow improved and Qinghua 20 channel checks remained relatively orderly; against that, outside-province revenue fell 15.4% and the wider category remains in contraction.

Distributor deleveraging does not look like the primary near-term mechanism. If dealers were broadly unable or unwilling to fund the business, a near-CNY0.9bn sequential increase in contract liabilities and stronger operating cash flow would be difficult to reconcile. There can still be regional dealer stress, but aggregate cash behavior is better than the revenue line.

End-demand loss is the deeper issue because controlled destocking has to be responding to something. The industry’s 2025 sales contraction, declining output, price inversion across many premium brands and Fenjiu’s own falling revenue per liter all point toward a smaller or more value-conscious end market.

Fenjiu’s relative share position nevertheless remains better than most listed competitors. In FY2025 the industry contracted while Fenjiu grew revenue. Luzhou, Yanghe and Gujing all reported double-digit revenue declines. Q1 2026 Fenjiu’s -9.7% also remained less severe than Luzhou’s -14.2% and Gujing’s -18.6%.

There is not enough audited industry data yet to calculate an exact Q1 2026 national revenue-share change or separate light-aroma from strong-aroma share with matching definitions. The responsible conclusion is narrower: Fenjiu clearly gained relative listed-company share through 2025 and remained a relative outperformer in Q1 2026, even though its own growth turned negative.

The market is currently trading the durability of that relative advantage. The stock is not priced for a return to the 2017–2021 growth regime. A TTM P/E around 13.7 times and dividend yield above 5% indicate a market that expects lower normalized growth and assigns a large discount to its former valuation.

Part of the decline is company-specific. FY2025’s profit miss relative to revenue growth, Q1’s first major contraction and the outside-province reversal undermine the nationalization growth story. Part is sector-wide. Comparable baijiu equities have been rerated down because wholesale prices, inventories, banquet demand and demographics have all become more uncertain. Some peers’ actual earnings have fallen 20–60%, so the multiple compression is reacting to real profit resets, not only sentiment.

The bullish evidence is specific. Qinghua 20’s surveyed wholesale price has stayed around the mid-CNY300s rather than collapsing; channel inventory has been reported below three months in some surveys; Bofen participates in a resilient value segment; Q1 operating cash flow rose; factory inventory fell; contract liabilities recovered; and Fenjiu continues to decline less than several direct peers.

The bearish evidence is equally specific. FY2025 gross-margin erosion and tax/marketing pressure appeared before revenue contracted; alcohol volume growth exceeded revenue growth by about 14.5 percentage points; year-end contract liabilities fell 19%; Q1 outside-province revenue fell 15.4% despite further distributor expansion; and the company is still spending on production capacity while the national category is shrinking.

What would distinguish a temporary reset from a broken nationalization thesis is not one quarter of group revenue. It is the combination of out-of-province sell-through, dealer productivity and Qinghua price architecture over the next several reporting periods.

Valuation, risk, catalysts and tracking

Historical P/E makes Fenjiu look cheap. Cash-flow valuation makes it less obviously so.

At CNY 123.52 and approximately 1.220bn shares, equity value is about CNY 150.69bn. Against FY2025 attributable profit of CNY 12.246bn, the stock trades at 12.30 times earnings. On a TTM basis after replacing Q1 2025 with Q1 2026, attributable profit is roughly CNY 10.98bn, or CNY 9.00 per share, giving the market-observed TTM P/E of approximately 13.72 times.

That is the headline valuation. The cash-flow passthrough test gives a different answer.

Over 2021–2025, cumulative operating cash flow was CNY 46.37bn against cumulative attributable profit of CNY 48.34bn, a 95.9% conversion ratio. There is no five-year evidence of a chronically fictitious accounting profit stream. In 2025 alone, however, the ratio dropped to 73.6%.

Cash capex in 2025 was CNY 1.194bn, producing crude free cash flow of about CNY 7.819bn. At the current market value, that is a 5.19% FCF yield and 19.3-times P/FCF. The difference from the 12.3-times headline P/E is more than 30%, so the report’s absolute valuation defaults to owner earnings instead of accounting earnings.

The company does not disclose maintenance versus growth capex. I estimate maintenance capex at about CNY 0.30bn for 2025, with roughly CNY 0.89bn treated as growth expenditure. This estimate rests on two observations: fixed-asset depreciation was only CNY 229m, while construction in progress increased CNY 855m and the company explicitly attributed that increase to major capacity projects. A maintenance estimate modestly above depreciation is therefore more defensible than treating all CNY 1.194bn as recurring maintenance. It remains an analytical estimate, not a company figure.

On that basis, 2025 owner earnings are approximately CNY 8.71bn, or CNY 7.14 per share. The current owner-earnings multiple is about 17.3 times and the owner-earnings yield about 5.8%. This is the more useful starting point for valuation.

That cash yield has an important relationship with the dividend. The CNY 8.00bn FY2025 dividend consumes about 92% of estimated owner earnings and slightly more than 100% of free cash flow after all capex. The payout can be funded because Fenjiu has cash and liquid financial assets, but at 2025 cash conversion the company cannot simultaneously grow capex, keep the payout rising rapidly and avoid drawing down financial assets indefinitely.

Peer P/E gives only partial information. Fenjiu’s 13.7-times TTM multiple is close to Luzhou Laojiao’s roughly 13.2 times and lower than Moutai and Wuliangye. Yanghe’s roughly 60-times TTM P/E says almost nothing about franchise superiority; its earnings denominator has collapsed. Wuliangye’s current trailing metrics are similarly complicated by its accounting correction.

The historical comparison is more striking. Fenjiu’s current multiple is near the bottom of its modern trading range and its price is nearly 68% below the 2021 peak. But a low historical percentile is not an absolute valuation argument. The 2021 multiple capitalized double-digit sales growth, expanding margins and nationwide dealer productivity. The present cash earnings are shrinking.

My valuation uses normalized owner earnings three years out instead of FY2025 reported EPS.

These are valuation scenarios within a research framework, not investment advice. The conservative scenario assumes the national expansion engine stalls and margin does not fully recover; the base case assumes 2026 is the trough, channel health improves and Fenjiu returns to mid-single-digit sales growth; the optimistic case requires successful Qinghua premiumization, continued share gains and renewed positive operating leverage.

The conservative catalyst is simply avoiding a deeper failure: Qinghua 20 stays above roughly CNY350 wholesale, contract liabilities remain healthy and out-of-province revenue stabilizes. Its permanent-loss trigger is two years of outside-province contraction accompanied by further gross-margin decline.

The base case requires a real operating turn rather than a multiple rerating by itself. Out-of-province revenue should return to positive growth during 2027, Qinghua pricing should stabilize without aggressive factory support, and OCF/net profit should return toward 0.9–1.0. A lower interest-rate environment helps the valuation but does not create the earnings.

The optimistic case assumes Fenjiu emerges from the shakeout as one of the largest share gainers, Bofen captures value-oriented demand without overwhelming the mix, Qinghua 20/25 deepen national penetration and the company proves that new capacity earns attractive returns.

The market’s near-term expectation is already negative. One current broker-estimate compilation around the base date projects 2026 revenue around CNY 34.3bn, down about 11%, and attributable profit around CNY 10.5bn, down about 14%. I use this only as evidence of prevailing expectations, not as an independent forecast or consensus series.

The expectation gap is asymmetric. Merely reporting another profit decline is unlikely to surprise investors. The positive surprise would be evidence that the channel reset is short: rising out-of-province sell-through, stable Qinghua prices and stronger contract liabilities with lower inventories. The negative surprise would be a second large decline in outside markets accompanied by falling wholesale prices.

The next scheduled financial disclosure is particularly important. Eastmoney’s company calendar shows Fenjiu’s 2026 interim report reserved for August 31, 2026. Because the base date is August 15, that report is not yet available to this analysis.

The margin-of-safety check is less flattering than the historical P/E.

Current CNY 123.52 is above the CNY 91–105 value range implied by my conservative scenario. On that definition, there is no discount to conservative value and therefore no classical margin of safety.

The most fragile base-case assumption is normalized owner earnings of roughly CNY 8.05 per share. Cutting that assumption to 70% gives about CNY 5.64. At a 16.5-times cash-earnings multiple, base value falls to roughly CNY 93 per share. That sensitivity shows why a low reported P/E does not eliminate permanent-loss risk.

If accounting earnings and the current valuation multiple stayed flat for three years and the CNY 6.56 dividend were maintained, expected nominal return would be approximately the dividend yield, around 5.3% annually before reinvestment effects. China’s official 10-year government bond yield was about 1.70% on August 14, 2026. The flat-earnings equity yield therefore exceeds the government yield by roughly 3.6 percentage points.

That spread is useful but insufficient for a margin-of-safety verdict because baijiu equity cash flows are riskier and the payout already consumes almost all estimated 2025 owner earnings. Margin-of-safety sufficiency verdict: none.

The permanent-loss risks are concrete.

The highest-probability risk is weaker national channel productivity. I rate probability high and impact high. The observable indicator is out-of-province revenue staying negative while distributor count remains flat or grows. The transmission path is falling revenue per distributor, weaker dealer returns, lower prepayments, higher factory support and ultimately a lower normalized owner-earnings base. Q1 2026 already contains the first part of that pattern.

The second risk is premium-mix erosion. Probability is medium-high and impact high. Watch Qinghua 20 wholesale price, Qinghua inventory and the gap between alcohol volume growth and revenue growth. If consumers trade down into Bofen and mid-tier products while Qinghua pricing weakens, physical volume can hold up but group gross margin can decline several points. FY2025’s 22% volume growth versus 7.5% revenue growth is the early warning.

The third risk is a structurally smaller baijiu profit pool. Probability is high and impact high. Industry production has already been falling for years, and 2025 produced simultaneous declines in output, revenue and profit. Fenjiu can beat the industry by taking share, but it cannot indefinitely compound at historical rates if the addressable profit pool contracts unless its share and mix rise substantially.

The fourth risk is overinvestment through the downcycle. Probability is medium and impact medium. Construction in progress rose 42% while the category contracted, and the 2030 expansion program is still being funded. Watch capex, construction-in-progress conversion and incremental gross profit. If new capacity comes on before demand recovers, returns on capital fall even with a debt-free balance sheet.

The fifth risk is governance execution during personnel transition. Probability is medium and impact medium. Two finance/IR leadership positions changed in late July. There is no disclosed disagreement, but the timing makes the 2026 interim report, cash-flow classification and working-capital commentary worth reading carefully. The risk transmission is principally valuation confidence rather than immediate solvency.

Food-safety risk is low probability but potentially very high impact for any baijiu brand. A serious quality incident would bypass normal cycle analysis and directly damage brand trust, distribution and valuation. I find no evidence in the latest filings of such an event; it remains a tail risk rather than a current thesis driver.

Positive catalysts are measurable, not thematic: out-of-province revenue returning to growth; Qinghua 20 wholesale moving sustainably above CNY365 without inventory building; QH25 establishing an independently observable wholesale market; contract liabilities remaining above the current recovery level; OCF/net income returning above 0.9; and management slowing growth capex if demand does not justify it.

Negative catalysts are the mirror image: another double-digit outside-province decline; Qinghua 20 below roughly CNY330 for a sustained period; channel inventory above four months; contract liabilities falling back below CNY6bn; gross margin falling below roughly 72%; or selling expense rising above 12% of revenue while sales remain negative.

The price and inventory ranges above are analytical monitoring thresholds, not company guidance. The next-report date comes from the public company calendar.

Cross-synthesis, key data, uncertainties and sources

Vertically, Fenjiu has proved that an old state-owned consumer brand can be transformed by incentives, commercial discipline and distribution execution. The reform period after 2017 is unusually clean evidence. Management was given explicit performance accountability; a strategic consumer-industry shareholder arrived; the company pushed beyond Shanxi; revenue and profit compounded rapidly; out-of-province sales became the majority of the business; and the stock was rerated from regional-SOE economics toward national premium-consumer economics.

That success was neither pure management genius nor pure industry luck. It required both. The baijiu environment allowed premiumization and rising concentration among major brands. Fenjiu’s reform gave it the ability to capture that tailwind faster than it had before. The evidence against attributing everything to the cycle is relative performance: Fenjiu moved from laggard to one of the sector’s fastest-growing large companies and continued gaining share even in 2025 while much of the listed peer set contracted.

The evidence against attributing everything to permanent company superiority is the timing. The extraordinary ten-year ROE and earnings record largely overlaps with the strongest part of the reform and baijiu upcycle. Investors who extrapolate that record into the next decade are implicitly assuming that national dealer expansion, premium mix and social demand can keep compounding together. FY2025 was the first hard indication that those variables can decouple.

What survives the cycle is valuable. Fenjiu still owns the strongest national light-aroma brand, a distribution network approaching 3,000 outside-province Fenjiu dealers, a mass product with national turnover, a premium Qinghua franchise, substantial aged inventory, a debt-light balance sheet and state-backed access to long-duration production assets. None of those disappears because one Q1 is weak.

What has weakened is the economics of incremental growth. FY2025 required 22% more alcohol volume for only 7.5% more revenue, while gross margin fell, selling intensity rose and tax burden increased. Profit stopped growing. Contract liabilities fell. Q1 then showed that outside-province revenue could contract even while the dealer network expanded. These signals are connected, not independent accidents.

Horizontally, Fenjiu’s strongest advantage is the shape of its portfolio. Moutai and Wuliangye own higher prestige at the top. Luzhou Laojiao converts premium revenue into profit more efficiently. Gujing has regional banquet depth. Yanghe historically built a formidable distributor system. Fenjiu alone among this selected group combines a nationally meaningful high-line mass bottle with a premium product family under the same principal aroma franchise.

That is why a broad industry downturn can actually improve Fenjiu’s relative position. Consumers trading down can migrate into Bofen; distributors reducing brand counts may keep Fenjiu because it turns quickly; light aroma gives it a taste of its own instead of another strong-aroma copy. The 2025 results show this relative resilience: Fenjiu grew while multiple peers fell double digits.

The same barbell can depress economics. Bofen is excellent for volume, shelf penetration and consumer acquisition but cannot produce Qinghua-level gross profit per bottle. If Bofen gains because consumers are trading down rather than because new consumers are later graduating into Qinghua, market share can rise while earnings quality falls. FY2025’s price/mix signal is consistent with that risk.

The current stock price rewards neither the old growth story nor a deep-distress story. At roughly 13.7 times TTM accounting earnings, the market has already compressed Fenjiu’s multiple dramatically. At roughly 17 times my estimate of 2025 owner earnings, however, the equity still requires a durable cash franchise. The valuation says “growth has slowed but the moat survives.” It does not say “earnings can fall indefinitely and the shareholder still wins.”

I think the market’s most important misjudgment can occur in both directions.

The overly bearish error is reading Q1 2026 as evidence that Fenjiu’s franchise has broken. Factory inventory fell, contract liabilities increased, cash flow improved, Qinghua 20 channel inventory appears manageable and the decline was still less severe than at several peers. That is not the fingerprint of a business in liquidity or channel collapse.

The overly bullish error is calling the entire decline voluntary destocking. Management does not voluntarily accept lower revenue in a vacuum. It is reducing channel pressure because industry demand and price architecture have weakened. FY2025 margin compression predated the shipment reset. A clean bill of health requires evidence of stable consumer pull at lower inventory, not merely lower factory shipments.

For the next 12 months, four variables dominate. First is out-of-province revenue: the nationalization thesis needs the Q1 -15.4% decline to narrow materially. Second is Qinghua 20 wholesale price and channel inventory. Third is contract liabilities, because dealer cash commitment should recover before reported sales fully reaccelerate. Fourth is gross margin: if volume stabilizes but the margin continues falling, Bofen/mid-tier mix is carrying too much of the recovery.

Over three years, dealer productivity matters more than dealer count. Fenjiu already has national physical coverage. The next stage cannot be another simple multiplication of distributors. It must generate more sell-through per productive dealer, deeper penetration in southern markets and a stronger Qinghua mix without forcing inventory onto the channel.

Over five years, the key question is whether Fenjiu can take enough category share to offset a mature or shrinking baijiu market. The company is investing in capacity as though it can. If weak producers exit and Fenjiu becomes one of a smaller number of national franchises, the strategy can work. If younger consumers permanently reduce high-proof baijiu occasions faster than consolidation offsets the decline, new capacity will earn lower returns.

A better investment setup would come from either price or evidence. The price route is straightforward: a share price in the low-CNY80s would discount my conservative normalized value by at least 20% and offer a genuine margin of safety even if recovery is slow. The evidence route would require out-of-province sales stabilizing, cash conversion returning toward 1.0, Qinghua prices staying firm and the company demonstrating that 2025’s mix deterioration has reversed. At the current price, neither route is fully satisfied.

My cross-synthesis is that Fenjiu remains a high-quality franchise, but normalized earnings are being rediscovered downward. The stock is already de-rated; the business reset is not yet finished.

Bull reasons:

• FY2025 Fenjiu revenue rose 7.52% while national baijiu industry revenue fell roughly 7.5%, showing meaningful share gains even before weaker peers completed their adjustment.
• Q1 2026 factory inventory fell about CNY0.74bn, contract liabilities rose about CNY0.90bn and operating cash flow increased 17.46%, evidence that the revenue decline included a genuine working-capital reset rather than a cash collapse.
• External channel checks place Qinghua 20 near CNY350–365 wholesale with inventory below roughly three months, materially healthier than a severely inverted premium SKU.
• A Bofen/Qinghua barbell lets Fenjiu participate simultaneously in consumer trading-down and premium recovery, a portfolio advantage most selected peers do not replicate.
• The balance sheet has substantial cash, negligible conventional debt and a 5.3% trailing dividend yield at the current price, giving the company time to manage the downcycle.

Bear reasons:

• FY2025 alcohol sales volume increased 21.99% while revenue rose only 7.52%, implying roughly 12% deterioration in a simple revenue-per-liter proxy and warning of weaker mix/realization.
• Fenjiu-brand gross margin fell 1.40 points, selling expenses rose faster than revenue and the tax/surcharge ratio increased 1.39 points before the group top line turned negative.
• Q1 2026 out-of-province revenue fell 15.41% while the outside Fenjiu distributor base still increased by 52, creating a clear dealer-productivity problem.
• Year-end 2025 contract liabilities fell 19.2% and operating cash flow fell 26%, evidence that dealer prepayment and earnings cash conversion weakened before the Q1 reset.
• Current valuation is 12.3 times FY2025 accounting profit but about 17.3 times estimated owner earnings; the apparent “cheapness” is significantly smaller once cash conversion is recognized.

Pre-mortem script one: during 2026–2027, Luzhou Laojiao, Gujing and other strong-aroma brands intensify discounting in the CNY300–500 banquet band while end demand remains weak. Qinghua 20 wholesale price falls from roughly CNY350–365 to below CNY300 and channel inventory climbs above four months. Fenjiu protects volume with Bofen and promotional support, but consolidated alcohol gross margin falls from around 75% toward 68–70%. Owner earnings fall from roughly CNY8.7bn to CNY6.0–6.5bn. At 12 times cash earnings, equity value would be around CNY59–64 per share, approximately half the present price.

Pre-mortem script two: the network continues to expand numerically while productive dealer economics deteriorate. Out-of-province revenue contracts for two years, contract liabilities fall below CNY6bn, Qinghua 25 fails to develop a stable wholesale market, and the company continues the 2030 capacity program. Attributable profit settles around CNY7–8bn and the market stops treating Fenjiu as a structural share gainer, assigning 10–11 times earnings. That combination puts the share price in roughly the CNY57–72 range and produces a 42–54% permanent capital loss from today.

The second script is the one I worry about more because it does not require a scandal or a dramatic industry collapse. It only requires several individually plausible things to happen together: slower sell-through, lower mix, continued capex and a lower terminal multiple.

At CNY123.52, Fenjiu offers a reasonable cash yield and historically low reported valuation, but it does not offer a conservative-value discount. The company remains financially strong and competitively better positioned than most mid-tier baijiu peers. The unresolved question is how much of 2025–2026 is an inventory reset versus a lower permanent earnings base. I would rather own the franchise after that answer becomes clearer or at a price that does not require the answer to be favorable.

The 12-month view is dominated by the August interim report and the 2027 Chinese New Year channel setup. The 3–5-year view is more constructive: consolidation should favor brands with Fenjiu’s recognition, balance sheet and distribution. The price paid still matters because the sector’s old growth multiple was built in a different demand environment.

【Company-profile scores】

• Fundamental quality: high
• Growth: medium
• Moat: strong
• Financial soundness: strong
• Management credibility: medium
• Valuation attractiveness: medium
• Risk level: medium
• Suitable investor type: value / dividend investors able to tolerate a consumer-cycle reset

【Investment rating】

• Rating: Hold
• One-line thesis: Brand strength survives, but FY2025 margin erosion and Q1’s 15% outside-province decline make current cash-based valuation fair rather than cheap.
• Ideal buy price: see the dedicated line below.
• Acceptable hold price: CNY 115–150.
• Clearly overvalued price: CNY 210–225.
• Current-price classification: acceptable hold.
• Whether to wait for a better price: yes. A price at or below CNY84 combined with Qinghua 20 above roughly CNY330, contract liabilities above CNY7bn and narrowing out-of-province declines would provide a materially better risk/reward. Waiting costs the approximately 5.3% trailing dividend yield and the possibility of missing a rapid rerating if the August 31 interim report shows an early channel turn.
• Target holding horizon: 3–5 years.
• Expected annualized return: conservative about -2.9%; base about +6.9%; optimistic about +18.0%, including the scenario dividend assumptions above.
• Max-loss risk: about 52–60% in the pre-mortem case where outside-province demand contracts for multiple years, Qinghua price architecture breaks, owner earnings fall toward CNY6bn and the cash-earnings multiple compresses to roughly 10–12 times.
• Reassessment-trigger signals: gross margin below 72% for two reporting periods; Qinghua 20 wholesale below CNY330 for a sustained period; out-of-province revenue negative for two successive reporting periods while dealer count rises; contract liabilities below CNY6bn; rolling OCF/net income below 0.75 without a clear working-capital explanation.

【Ideal Buy Price】72–84 CNY Basis: 20% or greater discount to the conservative CNY91–105 normalized owner-earnings valuation range.

【Valuation Range】

• current: 123.52 CNY (close as of 2026-08-14)
• bear (conservative · ideal buy zone): [72, 84]
• base (fair · acceptable hold zone): [115, 150]
• bull (optimistic · above the clearly-overvalued line): [210, 225]

The base and bull bands deliberately contain gaps. A CNY85–114 price would be below my normal hold range but not yet backed by the full conservative margin-of-safety discipline unless fundamentals remain intact; CNY151–209 would be increasingly expensive but still below the explicit overvaluation threshold.

Key-data snapshot:

Current price/valuation data are from market-data services as of August 14; government yield is from the ChinaBond Ministry of Finance government-bond curve; company financial metrics are from the 2025 Annual Report and Q1 2026 disclosure.

Research uncertainties are unusually important in this initiation.

First, Fenjiu does not disclose audited revenue, volume and gross margin separately for Qinghua, Bofen, Panama and Zhuyeqing in a way that allows a clean price-band profit bridge. The report can establish that Fenjiu-brand gross margin fell and volume grew much faster than sales; it cannot allocate the entire decline to Qinghua discounting versus Bofen mix.

Second, social inventory is not a balance-sheet item. Qinghua 20 inventory and wholesale prices used here come from broker/channel surveys. They are useful because several observations cluster around similar levels, but they are not audited. Qinghua 25 wholesale data are too thin for me to establish an investment-grade batch-price series.

Third, distributor count is a stock, not a sell-through measure. Revenue per year-end distributor is a diagnostic proxy; it can be distorted by dealer entry timing, product overlap, regional subsidiaries and the fact that reported regional revenue includes more than Fenjiu alone.

Fourth, maintenance capex is not disclosed. My CNY0.30bn estimate is based on depreciation and the identified expansion projects. If a materially larger portion of capex is economically necessary just to sustain existing earnings, owner earnings are lower than modeled.

Fifth, this report is deliberately frozen before the 2026 interim report scheduled for August 31. A material H1 change in contract liabilities, outside-province sales, Qinghua channel pricing or cash flow could move the conclusion quickly.

Source register: the principal company source is 《山西杏花村汾酒厂股份有限公司 2025 年年度报告》 (“Shanxi Xinghuacun Fen Wine Factory Co., Ltd. 2025 Annual Report”), filed in April 2026, including the audited income statement, cash-flow statement, geographic/product disclosures, taxes, expenses and capex.

The latest quarterly sources are 《山西杏花村汾酒厂股份有限公司 2026 年第一季度报告》 (“Shanxi Xinghuacun Fen Wine Factory Co., Ltd. 2026 First Quarter Report”) and 《2026 年第一季度经营数据公告》 (“2026 First Quarter Operating Data Announcement”), which provide the group, product, region, channel and dealer-count figures.

The principal reform source is the Shanxi state-asset coverage of the 2017 target-responsibility reform, supplemented by contemporaneous reporting on the management “military order.” The 2018 strategic-investor transaction is cross-checked to China Resources Enterprise’s own transaction history and JunHe’s transaction record.

Industry conditions are grounded in the China Alcoholic Drinks Association’s May 2026 review and national industry figures reproduced in Wuliangye’s 2025 disclosure; secondary channel evidence is used only where primary company filings cannot provide wholesale prices or social inventory.

Peer financials are drawn from the respective FY2025/Q1 2026 disclosures or reporting based directly on them: Luzhou Laojiao, Yanghe, Gujing Gongjiu and Wuliangye. Wuliangye is explicitly adjusted in the interpretation for its 2026 prior-period accounting correction.

Market valuation uses the August 14, 2026 close and contemporaneous TTM valuation data; historical price context uses the reported July 2021 all-time high. The risk-free comparison uses the official ChinaBond Ministry of Finance curve, where the 10-year yield was 1.70% on August 14.

Other tickers mentioned

• 600519.SHG — Kweichow Moutai, used only as an ultra-premium sauce-aroma valuation and franchise-quality reference rather than a like-for-like Fenjiu peer.
• 000858.SHE — Wuliangye, high-end strong-aroma benchmark whose current 2025/2026 comparisons are distorted by a major revenue-recognition correction.
• 000568.SHE — Luzhou Laojiao, premium strong-aroma peer with materially higher net margin and similar current TTM valuation.
• 002304.SHE — Yanghe, distributor-heavy regional/national baijiu franchise illustrating the earnings downside when channel momentum reverses.
• 000596.SHE — Gujing Gongjiu, Anhui-centered strong-aroma competitor with deep banquet-channel penetration and materially weaker 2025–Q1 2026 growth.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.